ULBI
Ultralife Corporation
6.10$
+2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.2% | +1.3% | -5.9% | +1.5% | +27.8% | +1.5% | -1.2% | +0.6% | -2.4% | +1.7% | -2.0% | |
| – | +0.7% | +4.5% | -11.2% | +3.2% | +12.4% | +4.4% | -2.4% | +1.6% | +5.2% | +4.1% | -2.7% | |
| – | +10.5% | -1.7% | -33.8% | +1.3% | +1.2% | +27.2% | +25.5% | -15.4% | +0.9% | -4.9% | -25.1% | |
| – | +10.5% | -1.7% | -33.8% | +1.3% | – | – | +25.5% | -15.4% | +0.9% | -4.9% | -25.1% | |
| – | +16.8% | +11.1% | -12.0% | -10.6% | +5.8% | +22.8% | -10.4% | -4.3% | +9.8% | +1.4% | +1.0% | |
| – | -9.5% | +3.8% | -5.5% | +6.3% | +16.8% | -6.8% | +5.7% | +4.3% | +2.4% | +6.1% | +2.5% | |
| – | +0.6% | -0.2% | +0.0% | +0.8% | +19.1% | +0.3% | +0.6% | -0.2% | +0.1% | -0.1% | +0.1% | |
| – | -1.1% | -1.6% | -1.5% | -1.1% | +69.5% | -1.5% | -1.4% | -1.8% | -53.3% | -2.6% | -2.5% | |
| – | -2.8% | -2.4% | -29.3% | +3.7% | +128.1% | +1.0% | -5.5% | +3.0% | +2.3% | +4.7% | -8.1% | |
| – | -10.1% | -1.5% | -12.0% | +27.4% | +11.8% | +7.5% | -5.1% | +12.7% | +10.8% | +15.3% | -13.2% | |
| – | +3.6% | -3.9% | +8.5% | -0.1% | – | – | +7.8% | +6.5% | -14.9% | -16.7% | -22.6% | |
| – | -15.8% | +17.5% | -27.2% | +30.9% | +11.7% | +17.4% | -9.6% | -5.8% | +23.0% | +38.1% | -6.1% | |
| – | -2.0% | -2.0% | -56.9% | -41.0% | +774.7% | -1.9% | -5.9% | -2.1% | -2.1% | -2.9% | -3.0% | |
| – | +3.0% | +2.8% | +3.4% | +0.9% | -0.4% | +1.8% | +1.5% | -0.9% | -5.3% | -0.3% | +2.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.1% | +0.2% | +1.9% | +0.3% | -1.4% | +0.3% | -0.1% | -0.1% | +0.0% | +0.0% | +0.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.